- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Duchenne muscular dystrophy: Sanofi owned biotech company sues Sarepta Therapeutics over patent infringement
![Duchenne muscular dystrophy: Sanofi owned biotech company sues Sarepta Therapeutics over patent infringement Duchenne muscular dystrophy: Sanofi owned biotech company sues Sarepta Therapeutics over patent infringement](https://medicaldialogues.in/h-upload/2024/01/27/750x450_231047-sanofi-50.webp)
Sanofi-owned biotech company Genzyme has initiated a lawsuit against competitor Sarepta Therapeutics in Delaware federal court, accusing the firm of patent infringement. The case centers on two patents allegedly violated by Sarepta's Duchenne muscular dystrophy (DMD) treatment, Elevidys.
Genzyme asserts in a lawsuit, which became public on Monday, that Sarepta's Elevidys treatment mimics Genzyme's technology. This technology involves modifying viruses to deliver genes into human cells, a critical component of gene-therapy treatments such as Elevidys.
For Genzyme: Katherine Helm, Noah Leibowitz, Martin Black, Sharon Gagliardi, Jonathan Loeb and Amanda Antons of Dechert
For Sarepta: Not yet available
Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751